Omezolan 10 (Omeprazole)

Omeprazole, the active ingredient in Omezolan 10, is a proton pump inhibitor presented as a 10 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Omezolan 10 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omezolan 10 contains omeprazole, a proton pump inhibitor that acts on the acid‑secretion pathway in the stomach. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Adverse reactions to omeprazole may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal discomfort: mild stomach pain or cramping. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatic stress. - Acute interstitial nephritis: kidney inflammation presenting with fever and flank pain.

When prescribing Omezolan 10, consider the following safety measures: - Assess renal and hepatic function: adjust use if impairment is present. - Review concomitant medications: omeprazole may affect absorption of other drugs. - Monitor long‑term users: watch for bone density loss and magnesium deficiency. - Use during pregnancy: limit to situations where benefit outweighs risk. - Use during lactation: weigh potential infant exposure against maternal benefit. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can interact with several medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity, increasing cardiovascular event risk. - Atazanavir: decreased absorption leading to sub‑therapeutic antiviral levels. - Methotrexate: increased serum concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential INR elevation; monitor coagulation parameters. - Digoxin: possible increase in serum digoxin levels. - Phenytoin: may reduce omeprazole plasma concentrations. - Diazepam: enhanced central nervous system depression. - Iron supplements: decreased iron absorption; separate dosing by at least 2 hours.